ePT--the Electronic Newsletter of Pharmaceutical Technology, Jan 3, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Jan 3, 2013
News
Mylan Recalls Painkiller Pills due to Risk of Higher Dosage
By Adeline Siew, PhD
Mylan issued a voluntary recall of three lots of the painkiller tablets hydrocodone bitartrate and acetaminophen.
GSK Partners with Vodafone for Vaccinations
By Stephanie Sutton
GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.
FDA Approvals of NMEs and BLAs Increased in 2012
By Patricia Van Arnum
Additional approvals in December have helped to outpace a recent high set in 2011.
BASF Extends Offer Period to Acquire Pronova BioPharma
By Adeline Siew, PhD
BASF extended its offer period to acquire Pronova BioPharma, a producer of omega-3 fatty acids.
Week of December 31, 2012: Mylan, Orion Enter Into Comtan Settlement Agreement; Takeda, Amylin Terminate Agreement to Codevelop and Commercialize Compounds for Obesity; and More
Mylan, Orion Enter Into Comtan Settlement Agreement; Takeda, Amylin Termination Agreement to Codevelop and Commercialize Compounds for Obesity; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here